GTC Biotherapeutics, Inc. (GTCB) Posts Q1 Loss of $0.26, Narrower Y/Y
GTC Biotherapeutics, Inc. (OTCBB: GTCB) reports Q1 loss of $0.26, versus ($0.99) reported for the same period a year ago. Revenue for the quarter was $346,000, compared to $198,000 in Q109.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Synopsys, Inc. (SNPS) Misses Q2 EPS by 2c; Issues Confident Q3 Outlook; Guides FY12
- Jiayuan.com (DATE) Reports In-Line Q1 EPS of 5c; Guides Q2 Revs
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
